Page last updated: 2024-08-07 23:53:45
Cytochrome P450 1B1
A cytochrome P450 1B1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q16678]
Synonyms
EC 1.14.14.1;
CYPIB1;
Hydroperoxy icosatetraenoate dehydratase;
4.2.1.152
Research
Bioassay Publications (35)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (11.43) | 29.6817 |
2010's | 23 (65.71) | 24.3611 |
2020's | 8 (22.86) | 2.80 |
Compounds (85)
Drugs with Inhibition Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
melatonin | Homo sapiens (human) | Ki | 14.0000 | 1 | 1 |
4-aminobenzoic acid | Homo sapiens (human) | IC50 | 120.0000 | 1 | 1 |
berberine | Homo sapiens (human) | IC50 | 0.9747 | 3 | 3 |
berberine | Homo sapiens (human) | Ki | 0.0440 | 1 | 1 |
5-methoxypsoralen | Homo sapiens (human) | IC50 | 15.3000 | 1 | 1 |
carvedilol | Homo sapiens (human) | IC50 | 1.1000 | 1 | 1 |
donepezil | Homo sapiens (human) | IC50 | 15.2400 | 1 | 1 |
fluoxetine | Homo sapiens (human) | IC50 | 475.0000 | 1 | 1 |
furafylline | Homo sapiens (human) | Ki | 200.0000 | 1 | 1 |
khellin | Homo sapiens (human) | IC50 | 34.6000 | 1 | 1 |
1,4-phenylenebis(methylene)selenocyanate | Homo sapiens (human) | IC50 | 0.1300 | 1 | 1 |
estrone | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
1,2,5,6-dibenzanthracene | Homo sapiens (human) | IC50 | 0.0090 | 1 | 1 |
alizarin | Homo sapiens (human) | Ki | 0.5000 | 1 | 1 |
purpurin | Homo sapiens (human) | IC50 | 2.2000 | 1 | 1 |
purpurin | Homo sapiens (human) | Ki | 0.7000 | 1 | 1 |
1,3-diphenyl-1-triazene | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
naphthazarin | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
plumbagin | Homo sapiens (human) | IC50 | 6.1500 | 1 | 1 |
imperatorin | Homo sapiens (human) | Ki | 1.0000 | 1 | 2 |
flavone | Homo sapiens (human) | IC50 | 0.6000 | 1 | 1 |
perillyl alcohol | Homo sapiens (human) | Ki | 2.0000 | 1 | 1 |
3-hydroxyflavone | Homo sapiens (human) | IC50 | 0.0900 | 1 | 1 |
alpha-naphthoflavone | Homo sapiens (human) | IC50 | 10.8787 | 34 | 34 |
alpha-naphthoflavone | Homo sapiens (human) | Ki | 0.0160 | 1 | 1 |
erythromycin | Homo sapiens (human) | IC50 | 40.0000 | 1 | 1 |
tranylcypromine | Homo sapiens (human) | IC50 | 6.2000 | 1 | 1 |
pyrene | Homo sapiens (human) | IC50 | 0.0020 | 2 | 2 |
4,5'-dimethylangelicin | Homo sapiens (human) | Ki | 7.4600 | 1 | 1 |
3,4,5,3',4'-pentachlorobiphenyl | Homo sapiens (human) | IC50 | 0.0110 | 1 | 1 |
proadifen hydrochloride | Homo sapiens (human) | IC50 | 19.0000 | 1 | 1 |
rutecarpine | Homo sapiens (human) | IC50 | 0.0550 | 2 | 2 |
2-methoxyestradiol | Homo sapiens (human) | Ki | 36.0000 | 1 | 1 |
pinocembrin | Homo sapiens (human) | IC50 | 1.6790 | 1 | 1 |
isopimpinellin | Homo sapiens (human) | IC50 | 6.3800 | 1 | 1 |
isopimpinellin | Homo sapiens (human) | Ki | 11.0000 | 1 | 2 |
isoimperatorin | Homo sapiens (human) | Ki | 6.0000 | 1 | 2 |
5-hydroxyflavone | Homo sapiens (human) | IC50 | 0.2100 | 1 | 1 |
4-methoxyestradiol | Homo sapiens (human) | Ki | 149.0000 | 1 | 1 |
pirlindole | Homo sapiens (human) | IC50 | 36.0000 | 1 | 1 |
hesperetin | Homo sapiens (human) | IC50 | 0.5110 | 1 | 1 |
homoeriodictyol | Homo sapiens (human) | IC50 | 0.9780 | 2 | 2 |
eupatorin | Homo sapiens (human) | Ki | 0.0350 | 2 | 2 |
phellopterin | Homo sapiens (human) | IC50 | 0.2200 | 1 | 1 |
karanjin | Homo sapiens (human) | IC50 | 2.0650 | 2 | 2 |
benzyl selenocyanate | Homo sapiens (human) | IC50 | 0.1300 | 1 | 1 |
16-fluoro-5-androsten-17-one | Homo sapiens (human) | IC50 | 1.5000 | 2 | 2 |
5-hydroxy-3',4',6,7-tetramethoxyflavone | Homo sapiens (human) | IC50 | 2.5000 | 1 | 1 |
cirsiliol | Homo sapiens (human) | Ki | 0.8000 | 1 | 1 |
isosakuranetin | Homo sapiens (human) | IC50 | 1.0240 | 1 | 1 |
demethyleneberberine | Homo sapiens (human) | IC50 | 9.9000 | 1 | 1 |
naringenin | Homo sapiens (human) | IC50 | 3.6560 | 1 | 1 |
eriodictyol | Homo sapiens (human) | IC50 | 1.2840 | 1 | 1 |
resveratrol | Homo sapiens (human) | IC50 | 28.2000 | 2 | 2 |
resveratrol | Homo sapiens (human) | Ki | 3.2318 | 4 | 4 |
cannabidiol | Homo sapiens (human) | Ki | 3.6300 | 1 | 1 |
pongamol | Homo sapiens (human) | IC50 | 6.0400 | 1 | 1 |
thalifendine | Homo sapiens (human) | IC50 | 4.1000 | 1 | 1 |
uccf-029 | Homo sapiens (human) | IC50 | 0.0093 | 1 | 1 |
quercetin | Homo sapiens (human) | IC50 | 1.1108 | 5 | 5 |
quercetin | Homo sapiens (human) | Ki | 0.0230 | 2 | 2 |
acacetin | Homo sapiens (human) | IC50 | 0.0110 | 3 | 3 |
acacetin | Homo sapiens (human) | Ki | 0.0070 | 2 | 2 |
apigenin | Homo sapiens (human) | IC50 | 0.1925 | 2 | 2 |
apigenin | Homo sapiens (human) | Ki | 0.0640 | 1 | 1 |
luteolin | Homo sapiens (human) | IC50 | 0.2195 | 2 | 2 |
luteolin | Homo sapiens (human) | Ki | 1.2280 | 2 | 2 |
pinosylvin | Homo sapiens (human) | Ki | 0.0743 | 1 | 1 |
chrysoeriol | Homo sapiens (human) | IC50 | 0.0198 | 2 | 2 |
kaempferol | Homo sapiens (human) | IC50 | 0.0470 | 1 | 1 |
kaempferol | Homo sapiens (human) | Ki | 0.0430 | 1 | 1 |
baicalein | Homo sapiens (human) | Ki | 0.2600 | 1 | 1 |
chrysin | Homo sapiens (human) | IC50 | 0.1520 | 2 | 2 |
chrysin | Homo sapiens (human) | Ki | 0.0160 | 2 | 2 |
diosmetin | Homo sapiens (human) | IC50 | 0.0290 | 1 | 1 |
diosmetin | Homo sapiens (human) | Ki | 0.0160 | 2 | 2 |
galangin | Homo sapiens (human) | IC50 | 0.0140 | 2 | 2 |
genkwanin | Homo sapiens (human) | Ki | 2.3400 | 1 | 1 |
3-methylquercetin | Homo sapiens (human) | IC50 | 0.0170 | 1 | 1 |
kaempferide | Homo sapiens (human) | IC50 | 0.0155 | 2 | 2 |
myricetin | Homo sapiens (human) | Ki | 0.0270 | 2 | 2 |
scutellarein | Homo sapiens (human) | Ki | 0.2200 | 1 | 1 |
tamarixetin | Homo sapiens (human) | IC50 | 0.0200 | 1 | 1 |
trans-2,3',4,5'-tetrahydroxystilbene | Homo sapiens (human) | IC50 | 34.0000 | 2 | 2 |
pterostilbene | Homo sapiens (human) | Ki | 0.9100 | 1 | 1 |
7-hydroxyflavone | Homo sapiens (human) | IC50 | 0.2500 | 1 | 1 |
2,4,3',5'-tetramethoxystilbene | Homo sapiens (human) | IC50 | 0.0060 | 4 | 4 |
2,4,3',5'-tetramethoxystilbene | Homo sapiens (human) | Ki | 0.0030 | 1 | 1 |
3,3',4,5'-tetramethoxy-trans-stilbene | Homo sapiens (human) | IC50 | 3.0000 | 1 | 1 |
3,4',5-trimethoxystilbene | Homo sapiens (human) | IC50 | 0.7900 | 1 | 1 |
bergamottin | Homo sapiens (human) | Ki | 587.0000 | 1 | 2 |
pinostilbene | Homo sapiens (human) | Ki | 0.9000 | 1 | 1 |
3,5-dihydroxy-4'-methoxystilbene | Homo sapiens (human) | Ki | 2.0600 | 1 | 1 |
indacaterol | Homo sapiens (human) | IC50 | 59.2000 | 1 | 1 |
eupatorin-5-methyl ether | Homo sapiens (human) | Ki | 0.6700 | 1 | 1 |
pifithrin-alpha | Homo sapiens (human) | IC50 | 0.0206 | 1 | 1 |
pifithrin-alpha | Homo sapiens (human) | Ki | 0.0044 | 1 | 1 |
kaf156 | Homo sapiens (human) | IC50 | 6.0000 | 1 | 1 |
Drugs with Activation Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
alpha-naphthoflavone | Homo sapiens (human) | EC50 | 26.7000 | 3 | 3 |
quercetin | Homo sapiens (human) | EC50 | 1.1000 | 1 | 1 |
Drugs with Other Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
imidazole | Homo sapiens (human) | Ks | 1,255.0000 | 1 | 1 |
alpha-naphthoflavone | Homo sapiens (human) | Ks | 0.7000 | 1 | 1 |
Discovery of heterocycle-containing α-naphthoflavone derivatives as water-soluble, highly potent and selective CYP1B1 inhibitors.European journal of medicinal chemistry, , Jan-01, Volume: 209, 2021
Synthesis and structure-activity relationship studies of α-naphthoflavone derivatives as CYP1B1 inhibitors.European journal of medicinal chemistry, , Feb-01, Volume: 187, 2020
Design and synthesis of α-naphthoflavone chimera derivatives able to eliminate cytochrome P450 (CYP)1B1-mediated drug resistance via targeted CYP1B1 degradation.European journal of medicinal chemistry, , Mar-01, Volume: 189, 2020
Development of benzochalcone derivatives as selective CYP1B1 inhibitors and anticancer agents.MedChemComm, , Sep-01, Volume: 10, Issue:9, 2019
Design and synthesis of selective CYP1B1 inhibitor via dearomatization of α-naphthoflavone.Bioorganic & medicinal chemistry, , 01-15, Volume: 27, Issue:2, 2019
Adaptable Small Ligand of CYP1 Enzymes for Use in Understanding the Structural Features Determining Isoform Selectivity.ACS medicinal chemistry letters, , Dec-13, Volume: 9, Issue:12, 2018
Targeting Cytochrome P450 (CYP) 1B1 Enzyme with Four Series of A-Ring Substituted Estrane Derivatives: Design, Synthesis, Inhibitory Activity, and Selectivity.Journal of medicinal chemistry, , 10-25, Volume: 61, Issue:20, 2018
[no title available]Bioorganic & medicinal chemistry, , 12-15, Volume: 26, Issue:23-24, 2018
Structure-Based Design and Synthesis of New Estrane-Pyridine Derivatives as Cytochrome P450 (CYP) 1B1 Inhibitors.ACS medicinal chemistry letters, , Nov-09, Volume: 8, Issue:11, 2017
Inhibitors of cytochrome P450 (CYP) 1B1.European journal of medicinal chemistry, , Jul-28, Volume: 135, 2017
(E)-3-(3,4,5-Trimethoxyphenyl)-1-(pyridin-4-yl)prop-2-en-1-one, a heterocyclic chalcone is a potent and selective CYP1A1 inhibitor and cancer chemopreventive agent.Bioorganic & medicinal chemistry letters, , 12-15, Volume: 27, Issue:24, 2017
Quinazoline derivatives as selective CYP1B1 inhibitors.European journal of medicinal chemistry, , Apr-21, Volume: 130, 2017
Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines.European journal of medicinal chemistry, , Mar-31, Volume: 129, 2017
[no title available]Bioorganic & medicinal chemistry letters, , 12-15, Volume: 27, Issue:24, 2017
Synthesis and biological evaluation of pyrrole-based chalcones as CYP1 enzyme inhibitors, for possible prevention of cancer and overcoming cisplatin resistance.Bioorganic & medicinal chemistry letters, , 08-15, Volume: 27, Issue:16, 2017
Targeting cytochrome P450 (CYP) 1B1 with steroid derivatives.Bioorganic & medicinal chemistry letters, , 11-01, Volume: 26, Issue:21, 2016
A Ligand-Based Drug Design. Discovery of 4-Trifluoromethyl-7,8-pyranocoumarin as a Selective Inhibitor of Human Cytochrome P450 1A2.Journal of medicinal chemistry, , Aug-27, Volume: 58, Issue:16, 2015
Design and Synthesis of New α-Naphthoflavones as Cytochrome P450 (CYP) 1B1 Inhibitors To Overcome Docetaxel-Resistance Associated with CYP1B1 Overexpression.Journal of medicinal chemistry, , Apr-23, Volume: 58, Issue:8, 2015
Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.Bioorganic & medicinal chemistry, , Aug-01, Volume: 15, Issue:15, 2007
Inhibitors of cytochrome P450 (CYP) 1B1.European journal of medicinal chemistry, , Jul-28, Volume: 135, 2017
Effect of structural modification on the inhibitory selectivity of rutaecarpine derivatives on human CYP1A1, CYP1A2, and CYP1B1.Bioorganic & medicinal chemistry letters, , Aug-04, Volume: 13, Issue:15, 2003
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.Bioorganic & medicinal chemistry, , Sep-01, Volume: 18, Issue:17, 2010
Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.Bioorganic & medicinal chemistry, , Aug-01, Volume: 15, Issue:15, 2007
Phytoestrogens and their synthetic analogues as substrate mimic inhibitors of CYP1B1.European journal of medicinal chemistry, , Feb-01, Volume: 163, 2019
Inhibitors of cytochrome P450 (CYP) 1B1.European journal of medicinal chemistry, , Jul-28, Volume: 135, 2017
Aryl morpholino triazenes inhibit cytochrome P450 1A1 and 1B1.Bioorganic & medicinal chemistry letters, , 07-15, Volume: 26, Issue:14, 2016
Synthesis of unnatural flavonoids and stilbenes by exploiting the plant biosynthetic pathway in Escherichia coli.Chemistry & biology, , Volume: 14, Issue:6, 2007
Quinazoline derivatives as selective CYP1B1 inhibitors.European journal of medicinal chemistry, , Apr-21, Volume: 130, 2017
Inhibitors of cytochrome P450 (CYP) 1B1.European journal of medicinal chemistry, , Jul-28, Volume: 135, 2017
[no title available]Bioorganic & medicinal chemistry letters, , 12-15, Volume: 27, Issue:24, 2017
Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.Bioorganic & medicinal chemistry, , May-01, Volume: 19, Issue:9, 2011
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.Bioorganic & medicinal chemistry, , Sep-01, Volume: 18, Issue:17, 2010
Inhibitors of cytochrome P450 (CYP) 1B1.European journal of medicinal chemistry, , Jul-28, Volume: 135, 2017
Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.Bioorganic & medicinal chemistry, , May-01, Volume: 19, Issue:9, 2011
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.Bioorganic & medicinal chemistry, , Sep-01, Volume: 18, Issue:17, 2010
Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.Bioorganic & medicinal chemistry, , Aug-01, Volume: 15, Issue:15, 2007
Inhibitors of cytochrome P450 (CYP) 1B1.European journal of medicinal chemistry, , Jul-28, Volume: 135, 2017
Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.Bioorganic & medicinal chemistry, , May-01, Volume: 19, Issue:9, 2011
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.Bioorganic & medicinal chemistry, , Sep-01, Volume: 18, Issue:17, 2010
Inhibitors of cytochrome P450 (CYP) 1B1.European journal of medicinal chemistry, , Jul-28, Volume: 135, 2017
Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.Bioorganic & medicinal chemistry, , May-01, Volume: 19, Issue:9, 2011
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.Bioorganic & medicinal chemistry, , Sep-01, Volume: 18, Issue:17, 2010
Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.Bioorganic & medicinal chemistry, , May-01, Volume: 19, Issue:9, 2011
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.Bioorganic & medicinal chemistry, , Sep-01, Volume: 18, Issue:17, 2010
Inhibitors of cytochrome P450 (CYP) 1B1.European journal of medicinal chemistry, , Jul-28, Volume: 135, 2017
Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.Bioorganic & medicinal chemistry, , May-01, Volume: 19, Issue:9, 2011
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.Bioorganic & medicinal chemistry, , Sep-01, Volume: 18, Issue:17, 2010
Inhibitors of cytochrome P450 (CYP) 1B1.European journal of medicinal chemistry, , Jul-28, Volume: 135, 2017
Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.Bioorganic & medicinal chemistry, , May-01, Volume: 19, Issue:9, 2011
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.Bioorganic & medicinal chemistry, , Sep-01, Volume: 18, Issue:17, 2010
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.Bioorganic & medicinal chemistry, , Sep-01, Volume: 18, Issue:17, 2010
Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.Bioorganic & medicinal chemistry, , Aug-01, Volume: 15, Issue:15, 2007
Aryl morpholino triazenes inhibit cytochrome P450 1A1 and 1B1.Bioorganic & medicinal chemistry letters, , 07-15, Volume: 26, Issue:14, 2016
Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors.Journal of medicinal chemistry, , Jan-03, Volume: 45, Issue:1, 2002
Phytoestrogens and their synthetic analogues as substrate mimic inhibitors of CYP1B1.European journal of medicinal chemistry, , Feb-01, Volume: 163, 2019
Adaptable Small Ligand of CYP1 Enzymes for Use in Understanding the Structural Features Determining Isoform Selectivity.ACS medicinal chemistry letters, , Dec-13, Volume: 9, Issue:12, 2018
Inhibitors of cytochrome P450 (CYP) 1B1.European journal of medicinal chemistry, , Jul-28, Volume: 135, 2017
Aryl morpholino triazenes inhibit cytochrome P450 1A1 and 1B1.Bioorganic & medicinal chemistry letters, , 07-15, Volume: 26, Issue:14, 2016
Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors.Journal of medicinal chemistry, , Jan-03, Volume: 45, Issue:1, 2002
Enables
This protein enables 8 target(s):
Target | Category | Definition |
monooxygenase activity | molecular function | Catalysis of the incorporation of one atom from molecular oxygen into a compound and the reduction of the other atom of oxygen to water. [ISBN:0198506732] |
iron ion binding | molecular function | Binding to an iron (Fe) ion. [GOC:ai] |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | molecular function | Catalysis of an oxidation-reduction (redox) reaction in which hydrogen or electrons are transferred from reduced flavin or flavoprotein and one other donor, and one atom of oxygen is incorporated into one donor. [GOC:mah] |
heme binding | molecular function | Binding to a heme, a compound composed of iron complexed in a porphyrin (tetrapyrrole) ring. [GOC:ai] |
aromatase activity | molecular function | Catalysis of the reduction of an aliphatic ring to yield an aromatic ring. [GOC:cb] |
estrogen 16-alpha-hydroxylase activity | molecular function | Catalysis of the reaction: estrogen + donor-H2 + O2 = 16-alpha-hydroxyestrogen + H2O. [GOC:BHF] |
hydroperoxy icosatetraenoate dehydratase activity | molecular function | A hydroperoxy icosatetraenoate = an oxoicosatetraenoate + H2O. [PMID:12881489, RHEA:55556] |
Located In
This protein is located in 2 target(s):
Target | Category | Definition |
mitochondrion | cellular component | A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. [GOC:giardia, ISBN:0198506732] |
endoplasmic reticulum membrane | cellular component | The lipid bilayer surrounding the endoplasmic reticulum. [GOC:mah] |
Active In
This protein is active in 1 target(s):
Target | Category | Definition |
intracellular membrane-bounded organelle | cellular component | Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane. [GOC:go_curators] |
Involved In
This protein is involved in 55 target(s):
Target | Category | Definition |
angiogenesis | biological process | Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels. [ISBN:0878932453] |
trabecular meshwork development | biological process | The progression of the trabecular meshwork over time, from its formation to the mature structure. The trabecular meshwork is a fenestrated endothelial-like tissue situated at the intersection of the cornea and the iris. The trabecular meshwork provides drainage for the aqueous humor. [PMID:20568247] |
DNA modification | biological process | The covalent alteration of one or more nucleotide sites in DNA, resulting in a change in its properties. [GOC:jl, GOC:ma] |
xenobiotic metabolic process | biological process | The chemical reactions and pathways involving a xenobiotic compound, a compound foreign to the organim exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical. [GOC:cab2, GOC:krc] |
nitric oxide biosynthetic process | biological process | The chemical reactions and pathways resulting in the formation of nitric oxide, nitrogen monoxide (NO), a colorless gas only slightly soluble in water. [GOC:ai] |
cell adhesion | biological process | The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules. [GOC:hb, GOC:pf] |
response to nutrient | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus. [GOC:go_curators] |
steroid metabolic process | biological process | The chemical reactions and pathways involving steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus. [ISBN:0198547684] |
estrogen metabolic process | biological process | The chemical reactions and pathways involving estrogens, C18 steroid hormones that can stimulate the development of female sexual characteristics. Also found in plants. [ISBN:0198506732] |
negative regulation of cell population proliferation | biological process | Any process that stops, prevents or reduces the rate or extent of cell proliferation. [GOC:go_curators] |
male gonad development | biological process | The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure. [GOC:jid] |
intrinsic apoptotic signaling pathway in response to oxidative stress | biological process | The series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced in response to oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, and ends when the execution phase of apoptosis is triggered. [GOC:ai, GOC:mtg_apoptosis] |
toxin metabolic process | biological process | The chemical reactions and pathways involving a toxin, a poisonous compound (typically a protein) that is produced by cells or organisms and that can cause disease when introduced into the body or tissues of an organism. [GOC:cab2] |
positive regulation of vascular endothelial growth factor production | biological process | Any process that increases or activates the frequency, rate, or extent of production of vascular endothelial growth factor. [GOC:BHF, GOC:rl] |
positive regulation of smooth muscle cell migration | biological process | Any process that activates, maintains or increases the frequency, rate or extent of smooth muscle cell migration. [CL:0000192, GOC:mtg_muscle] |
sterol metabolic process | biological process | The chemical reactions and pathways involving sterols, steroids with one or more hydroxyl groups and a hydrocarbon side-chain in the molecule. [ISBN:0198547684] |
arachidonic acid metabolic process | biological process | The chemical reactions and pathways involving arachidonic acid, a straight chain fatty acid with 20 carbon atoms and four double bonds per molecule. Arachidonic acid is the all-Z-(5,8,11,14)-isomer. [ISBN:0198506732] |
epoxygenase P450 pathway | biological process | The chemical reactions and pathways by which arachidonic acid is converted to other compounds including epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids. [GOC:mah, PMID:17979511] |
collagen fibril organization | biological process | Any process that determines the size and arrangement of collagen fibrils within an extracellular matrix. [GOC:mah, ISBN:0815316194] |
adrenal gland development | biological process | The process whose specific outcome is the progression of the adrenal gland over time, from its formation to the mature structure. This gland can either be a discrete structure located bilaterally above each kidney, or a cluster of cells in the head kidney that perform the functions of the adrenal gland. In either case, this organ consists of two cells types, aminergic chromaffin cells and steroidogenic cortical cells. [GOC:dgh] |
negative regulation of cell migration | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of cell migration. [GOC:go_curators] |
negative regulation of NF-kappaB transcription factor activity | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of the transcription factor NF-kappaB. [GOC:dph, GOC:rl, GOC:tb] |
response to follicle-stimulating hormone | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a follicle-stimulating hormone stimulus. [GOC:mah] |
response to estradiol | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen. [GOC:mah, ISBN:0911910123] |
negative regulation of cell adhesion mediated by integrin | biological process | Any process that stops, prevents, or reduces the frequency, rate, or extent of cell adhesion mediated by integrin. [GOC:add] |
benzene-containing compound metabolic process | biological process | The chemical reactions and pathways involving benzene, C6H6, a volatile, very inflammable liquid, contained in the naphtha produced by the destructive distillation of coal, from which it is separated by fractional distillation, or any of its derivatives. [GOC:jl] |
retinol metabolic process | biological process | The chemical reactions and pathways involving retinol, one of the three compounds that makes up vitamin A. [GOC:jl, http://www.indstate.edu/thcme/mwking/vitamins.html, PMID:1924551] |
retinal metabolic process | biological process | The chemical reactions and pathways involving retinal, a compound that plays an important role in the visual process in most vertebrates. In the retina, retinal combines with opsins to form visual pigments. Retinal is one of the forms of vitamin A. [ISBN:0198506732] |
positive regulation of apoptotic process | biological process | Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. [GOC:jl, GOC:mtg_apoptosis] |
blood vessel endothelial cell migration | biological process | The orderly movement of an endothelial cell into the extracellular matrix in order to form new blood vessels during angiogenesis. [PMID:11166264] |
endothelial cell migration | biological process | The orderly movement of an endothelial cell into the extracellular matrix to form an endothelium. [GOC:go_curators] |
estrous cycle | biological process | A type of ovulation cycle, which occurs in most mammalian therian females, where the endometrium is resorbed if pregnancy does not occur. [GOC:jl, Wikipedia:Estrous_cycle] |
positive regulation of translation | biological process | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA. [GOC:dph, GOC:go_curators, GOC:tb] |
positive regulation of angiogenesis | biological process | Any process that activates or increases angiogenesis. [GOC:go_curators] |
positive regulation of receptor signaling pathway via JAK-STAT | biological process | Any process that activates or increases the frequency, rate or extent of the JAK-STAT signaling pathway activity. [GOC:bf] |
membrane lipid catabolic process | biological process | The chemical reactions and pathways resulting in the breakdown of membrane lipids, any lipid found in or associated with a biological membrane. [GOC:ai] |
response to arsenic-containing substance | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an arsenic stimulus from compounds containing arsenic, including arsenates, arsenites, and arsenides. [GOC:hjd, ISBN:0721662544] |
blood vessel morphogenesis | biological process | The process in which the anatomical structures of blood vessels are generated and organized. The blood vessel is the vasculature carrying blood. [GOC:jid] |
retinal blood vessel morphogenesis | biological process | The process whose specific outcome is the progression of a blood vessel of the retina over time, from its formation to the mature structure. [GOC:BHF, GOC:dph] |
ganglion development | biological process | The process whose specific outcome is the progression of a ganglion over time, from its formation to the mature structure. [GOC:dph] |
cellular response to hydrogen peroxide | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus. [CHEBI:16240, GOC:mah] |
cellular response to cAMP | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus. [GOC:mah] |
cellular response to tumor necrosis factor | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus. [GOC:mah] |
cellular response to luteinizing hormone stimulus | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a luteinizing hormone stimulus. [GOC:mah] |
cellular response to cortisol stimulus | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cortisol stimulus. Cortisol is the major natural glucocorticoid synthesized in the zona fasciculata of the adrenal cortex; it affects the metabolism of glucose, protein, and fats and has appreciable mineralocorticoid activity. It also regulates the immune system and affects many other functions. [GOC:mah] |
cellular response to progesterone stimulus | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a progesterone stimulus. [GOC:mah] |
response to dexamethasone | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dexamethasone stimulus. [GOC:mah, GOC:yaf] |
endothelial cell-cell adhesion | biological process | The attachment of an endothelial cell to another endothelial cell via adhesion molecules. [GOC:BHF] |
response to indole-3-methanol | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an indole-3-methanol stimulus. [GOC:mah, GOC:yaf] |
cellular response to toxic substance | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a toxic stimulus. [GOC:pr] |
omega-hydroxylase P450 pathway | biological process | The chemical reactions and pathways by which arachidonic acid is converted to other compounds initially by omega-hydroxylation. [GOC:mw, PMID:10681399] |
response to 3-methylcholanthrene | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 3-methylcholanthrene stimulus. [GO_REF:0000071, GOC:mr, GOC:TermGenie, PMID:9224771] |
regulation of reactive oxygen species metabolic process | biological process | Any process that modulates the frequency, rate or extent of reactive oxygen species metabolic process. [GOC:mah] |
positive regulation of reactive oxygen species metabolic process | biological process | Any process that activates or increases the frequency, rate or extent of reactive oxygen species metabolic process. [GOC:mah] |
positive regulation of DNA biosynthetic process | biological process | Any process that activates or increases the frequency, rate or extent of DNA biosynthetic process. [GOC:obol] |